Kitty Yale
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 1
-
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Andrew Cheng (11 shared papers)Brian P. Kearney (8 shared papers)Edwin DeJesus (5 shared papers)Lijie Zhong (5 shared papers)Peter Ruane (5 shared papers)Kirsten White (3 shared papers)Javier Szwarcberg (2 shared papers)Tim Rolph (9 shared papers)
- Journals
- The Lancet (3 papers)Journal of Hepatology (3 papers)PEDIATRICS (2 papers)Antiviral Therapy (1 paper)AIDS (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Kitty Yale
20 papers receiving 2.0k citations
Kitty Yale's Hit Papers
Peers
Comparison fields: 5 of 66
- Virology 538
- Infectious Diseases 1.1k
- Emergency Medicine 300
- Hepatology 174
- Epidemiology 607
Countries citing papers authored by Kitty Yale
This map shows the geographic impact of Kitty Yale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kitty Yale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kitty Yale more than expected).
Fields of papers citing papers by Kitty Yale
This network shows the impact of papers produced by Kitty Yale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kitty Yale. The network helps show where Kitty Yale may publish in the future.
Co-authors
The 25 scholars most cited alongside Kitty Yale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 361 | |
| 2 | 2012 | 277 | |
| 3 | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial Hit paper breakdown → | 2021 | 271 |
| 4 | 2013 | 255 | |
| 5 | Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial Hit paper breakdown → | 2023 | 172 |
| 6 | 2006 | 138 | |
| 7 | 2011 | 96 | |
| 8 | 2005 | 77 | |
| 9 | 2022 | 75 | |
| 10 | 2006 | 62 | |
| 11 | 2013 | 61 | |
| 12 | Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study Hit paper breakdown → | 2024 | 50 |
| 13 | 2003 | 48 | |
| 14 | Efruxifermin in Compensated Liver Cirrhosis Caused by MASH Hit paper breakdown → | 2025 | 42 |
| 15 | 2010 | 36 | |
| 16 | 2024 | 19 | |
| 17 | 2004 | 16 | |
| 18 | 2025 | 15 | |
| 19 | 2024 | 1 | |
| 20 | 2022 | 1 |
About Kitty Yale
Kitty Yale is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Emergency Medicine and Virology, having authored 21 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Liver Disease Diagnosis and Treatment (7 papers), HIV-related health complications and treatments (3 papers), Fibroblast Growth Factor Research (3 papers), Kruppel-like factors research (2 papers), HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (1 paper) and Pharmacological Effects of Natural Compounds (1 paper). The work is most often cited by research in Virology (538 citations), Infectious Diseases (1.1k citations), Emergency Medicine (300 citations), Hepatology (174 citations) and Epidemiology (607 citations). Kitty Yale has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Andrew Cheng, Brian P. Kearney, Edwin DeJesus, Lijie Zhong, Peter Ruane, Kirsten White, Javier Szwarcberg, Tim Rolph, Erik J. Tillman and Brittany de Temple. Their work appears in journals such as The Lancet, Journal of Hepatology, PEDIATRICS, Antiviral Therapy and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.